Austrian Pharma Co.'s €142M Award Nixed In Germany
By Caroline Simson · February 16, 2022, 5:30 PM EST
A German court has set aside a €142 million ($161.8 million) damages award issued to Austrian pharmaceutical company AOP Orphan in the midst of a contentious dispute with Taiwanese drug developer...
To view the full article, register now.